Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Depreciation and Depletion (2018 - 2025)

enVVeno Medical has reported Depreciation and Depletion over the past 3 years, most recently at $33143.0 for Q4 2020.

  • For Q4 2020, Depreciation and Depletion rose 72.72% year-over-year to $33143.0; the TTM value through Dec 2020 reached $100000.0, up 117.31%, while the annual FY2025 figure was $100000.0, 50.0% down from the prior year.
  • Depreciation and Depletion for Q4 2020 was $33143.0 at enVVeno Medical, up from $21896.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $33143.0 in Q4 2020 and troughed at $2380.0 in Q1 2018.
  • A 3-year average of $13010.8 and a median of $11881.5 in 2019 define the central range for Depreciation and Depletion.
  • On a YoY basis, Depreciation and Depletion climbed as much as 584.83% in 2019 and fell as far as 28.78% in 2019.
  • Year by year, Depreciation and Depletion stood at $2802.0 in 2018, then surged by 584.83% to $19189.0 in 2019, then soared by 72.72% to $33143.0 in 2020.
  • Business Quant data shows Depreciation and Depletion for NVNO at $33143.0 in Q4 2020, $21896.0 in Q3 2020, and $25285.0 in Q2 2020.